focus -WSS

focus

author：fashion 2025-10-02 22:52:04 Page View：44123

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： It's time to retire 'poor historian' from clinicians' vocabularies
Next article： Drug repurposing or repositioning? The language matters

knowledge

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Military medical care influenced by rank and race, new study finds

SpencerPlatt/GettyImagesHigherrankingmilitaryofficersreceivemoreresourcesandbettercarethanlowranking

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

Glen Campbell's doctor discusses his public struggle with Alzheimer's

GlenCampbellperformsinIndio,Calif.,in2008.MichaelBuckner/GettyImagesGlenCampbell’sdecades-longmusica

focus

explore

knowledge

Glen Campbell's doctor discusses his public struggle with Alzheimer's